Maria Jose Bueno (Miguel Quintela-Fandino, M J Bueno)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 3

Top Topics

Clinical Practice

Inflammatory Response

Chemotherapy Induced

Papillary Thyroid

Top Venues

Current oncology reports

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Miguel Quintela-Fandino, Begoña Bermejo, Esther Zamora Adelantado, Fernando Moreno Antón, José Angel García-Saenz, Sonia Pernas, Noelia Martínez Jáñez, Desirée Jiménez, Encarna Adrover, R Andrés Conejero, Silvana Mourón, Maria Jose Bueno, Luis Manso Sanchez, Gemma Viñas, Emilio Alba, Antonio Llombart, Javier Cortes, Cristina Tebar, Denise J Roe, Adam Grant, Adam W Watson, Ramón Colomer, Ghassan Mouneimne
High mechanical conditioning by tumor extracellular matrix stiffness is a predictive biomarker for anti-fibrotic therapy in HER2-negative breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
S Mouron, Maria Jose Bueno, Ana Lluch, Luis Manso Sanchez, I Calvo, Javier Cortes, José Angel García-Saenz, M Gil-Gil, N Martinez-Janez, J V Apala, E Caleiras, Pilar Ximénez-Embún, J Muñoz, L Gonzalez-Cortijo, R Murillo, R Sánchez-Bayona, J M Cejalvo, G Gómez-López, Coral Fustero-Torre, Sergio Sabroso-Lasa, Núria Malats, M Martinez, A Moreno, D Megias, Marcos Malumbres, Ramón Colomer, Miguel Quintela-Fandino
Phosphoproteomic analysis of neoadjuvant breast cancer suggests that increased sensitivity to paclitaxel is driven by CDK4 and filamin A. Nature communications 13 (1) (2022)
Maria J Bueno, Jose L Ruiz-Sepulveda, Maria Jose Bueno
Mitochondrial Inhibition: a Treatment Strategy in Cancer? Current oncology reports 23 (4) (2021)